Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reperfusion adjunctive therapy.

J A Cairns1

  • 1Department of Medicine, McMaster University Medical Centre, Hamilton, Ontario, Canada.

Chest
|April 1, 1991
PubMed
Summary

Acetylsalicylic acid significantly improves survival when combined with coronary thrombolytic therapy and is recommended for routine use. Other adjunctive therapies show mixed results, with some lacking proven clinical benefit.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-effectiveness of alternative changes to a national blood collection service.

Transfusion medicine (Oxford, England)·2018
Same author

Pathophysiology of cardiogenic thromboembolism.

Platelets·2010
Same author

Left atrial myxoma mimicking vasculitis.

Canadian Medical Association journal·2010
Same author

Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids.

BJOG : an international journal of obstetrics and gynaecology·2008
Same author

TELEMAM: a cluster randomised trial to assess the use of telemedicine in multi-disciplinary breast cancer decision making.

European journal of cancer (Oxford, England : 1990)·2007
Same author

The coxibs and traditional nonsteroidal anti-inflammatory drugs: a current perspective on cardiovascular risks.

The Canadian journal of cardiology·2007

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Coronary thrombolytic therapy is a cornerstone in treating acute myocardial infarction.
  • Adjunctive therapies are explored to enhance the efficacy of thrombolysis.

Purpose of the Study:

  • To evaluate the efficacy of various adjunctive therapies in improving outcomes of coronary thrombolytic therapy.
  • To identify therapies with proven benefits versus those with theoretical advantages or unproven value.

Main Methods:

  • Review of clinical trials and existing data on adjunctive therapies used with thrombolysis.
  • Analysis of mortality reduction, angiographic outcomes, and clinical benefits.

Main Results:

  • Acetylsalicylic acid demonstrates marked mortality reduction and should be routine.
  • Heparin shows theoretical promise but lacks convincing clinical benefit data.
  • Beta-blockers, nitrates, calcium channel blockers, and ACE inhibitors have varied or unproven roles in acute settings.

Conclusions:

  • Acetylsalicylic acid is a proven, essential adjunctive therapy for thrombolysis.
  • The role of other adjunctive therapies requires further investigation, with some showing limited or no acute benefit.

Related Experiment Videos